Presentation

DISMANTLING BARRIERS IN PATIENT-LED RESEARCH: UTILIZING AN AI-ENHANCED ACCESS-CENTERED RESEARCH MODEL TO EVALUATE THE INTEGRATION OF PATIENT-REPORTED OUTCOMES IN FDA ORPHAN DRUG APPROVALS

Mar 18, 2026, 21:38 PM
EXPLORING THE ASSOCIATION BETWEEN CAREGIVER QOL AND THE CARE PROVIDED TO ADULTS WITH SEVERE VISUAL IMPAIRMENT CAUSED BY RARE DISEASE

Mar 18, 2026, 21:38 PM
AUTOMATED AMCP DOSSIER DEVELOPMENT USING A RETRIEVAL-AUGMENTED GENERATION (RAG)-BASED MULTI-AGENT APPROACH

Mar 18, 2026, 21:38 PM
ECONOMIC BURDEN AND USE OF GLUCOSE-LOWERING MEDICATIONS IN U.S. ADULTS WITH DIABETES, BY CARDIOVASCULAR-KIDNEY-METABOLIC COMPONENTS: 2012-2021

Mar 18, 2026, 21:38 PM
COST-MINIMIZATION AND BUDGET IMPACT ANALYSIS OF THE TRANSCATHETER PULMONARY VALVE VERSUS SURGICAL REPLACEMENT FOR RVOT DYSFUNCTION IN MEXICO

Mar 18, 2026, 21:38 PM
MULTIDISCIPLINARY TEAM MEETING IN DIGESTIVE CANCERS: “A 6-YEAR EXPERIENCE IN AN ALGERIAN REFERENCE CANCER CENTER”

Mar 18, 2026, 21:38 PM
CAREGIVER BURDEN AND SOCIOECONOMIC IMPACT OF HE AND OHE AMONG INDIVIDUALS CARING FOR PATIENTS WITH CIRRHOSIS

Mar 18, 2026, 21:38 PM
TERMINAL CARE COSTS IN JAPAN USING LINKED HEALTH AND LONG-TERM CARE CLAIMS: WHICH IS MORE EXPENSIVE—HOSPITAL DEATH OR LONG-TERM CARE FACILITY DEATH?

Mar 18, 2026, 21:38 PM
BORROWING STRENGTH WITHOUT BORROWING BIAS IN ONCOLOGY USING POWER PRIORS AND COMMENSURATE PRIORS FOR LONG TERM OVERALL SURVIVAL EXTRAPOLATION

Mar 18, 2026, 21:38 PM
EFFECT MODIFICATION BY MULTIMORBIDITY BURDEN ON THE EFFECTIVENESS AND SAFETY OF SGLT2 INHIBITORS IN OLDER ADULTS WITH T2D: A TARGET TRIAL EMULATION STUDY

Mar 18, 2026, 21:38 PM
FINANCIAL HARDSHIP, MEDICATION MANAGEMENT BEHAVIORS, AND PERCEIVED QUALITY OF CARE AMONG MEDICARE BENEFICIARIES

Mar 18, 2026, 21:38 PM
SIX MONTH OUTCOMES AND GLUCAGON-LIKE PEPTIDE-1 (GLP-1) THERAPY PERSISTENCE AMONG COMMERCIALLY INSURED ADULTS WITHOUT DIABETES IN AN OBESITY CARE MANAGEMENT PROGRAM

Mar 18, 2026, 21:38 PM
OPTIMIZING ENDPOINTS FOR CRSWNP BIOLOGIC TRIALS: REGULATORY, HTA, AND PATIENT-CENTERED EVIDENCE REQUIREMENTS

Mar 18, 2026, 21:38 PM
WHERE CAN PATIENTS HAVE AN IMPACT: A DEFINITION TO MEASURE PATIENT IMPACT

Mar 18, 2026, 21:38 PM
THE POTENTIAL EARLY IMPACT OF THE INFLATION REDUCTION ACT ON BUY-SIDE VALUATION METHODOLOGIES AND TRANSACTION STRUCTURING IN THE PHARMACEUTICAL INDUSTRY

Mar 18, 2026, 21:38 PM
INSIGHTS FOR AFFORDABILITY EFFORTS: ANALYZING DRUG AND NON-DRUG SPEND VIA STATE APCDS

Mar 18, 2026, 21:38 PM
SURVEILLANCE OF ADVERSE DRUG REACTIONS TO TRADITIONAL CHINESE MEDICINES: A REAL-WORLD ANALYSIS FROM SHENZHEN, CHINA

Mar 18, 2026, 21:38 PM
IS SUICIDAL IDEATION RISK ASSOCIATED WITH PHARMACOTHERAPY IN ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD)? A REAL-WORLD STUDY

Mar 18, 2026, 21:38 PM
UNDERSTANDING STAKEHOLDER PERSPECTIVES BETWEEN ENDOVASCULAR AND HYBRID REPAIR FOR THORACIC AORTIC ANEURYSMS AND DISSECTIONS INVOLVING THE LEFT SUBCLAVIAN ARTERY

Mar 18, 2026, 21:38 PM
TIME REALLOCATION AMONG ELDER CAREGIVERS IN THE UNITED STATES, 2011-2023

Mar 18, 2026, 21:38 PM

1
2
3
4
5
6
7
8
9
10 (current)

Presentation (CTI)

DISMANTLING BARRIERS IN PATIENT-LED RESEARCH: UTILIZING AN AI-ENHANCED ACCESS-CENTERED RESEARCH MODEL TO EVALUATE THE INTEGRATION OF PATIENT-REPORTED OUTCOMES IN FDA ORPHAN DRUG APPROVALS

EXPLORING THE ASSOCIATION BETWEEN CAREGIVER QOL AND THE CARE PROVIDED TO ADULTS WITH SEVERE VISUAL IMPAIRMENT CAUSED BY RARE DISEASE

AUTOMATED AMCP DOSSIER DEVELOPMENT USING A RETRIEVAL-AUGMENTED GENERATION (RAG)-BASED MULTI-AGENT APPROACH

ECONOMIC BURDEN AND USE OF GLUCOSE-LOWERING MEDICATIONS IN U.S. ADULTS WITH DIABETES, BY CARDIOVASCULAR-KIDNEY-METABOLIC COMPONENTS: 2012-2021

COST-MINIMIZATION AND BUDGET IMPACT ANALYSIS OF THE TRANSCATHETER PULMONARY VALVE VERSUS SURGICAL REPLACEMENT FOR RVOT DYSFUNCTION IN MEXICO

MULTIDISCIPLINARY TEAM MEETING IN DIGESTIVE CANCERS: “A 6-YEAR EXPERIENCE IN AN ALGERIAN REFERENCE CANCER CENTER”

CAREGIVER BURDEN AND SOCIOECONOMIC IMPACT OF HE AND OHE AMONG INDIVIDUALS CARING FOR PATIENTS WITH CIRRHOSIS

TERMINAL CARE COSTS IN JAPAN USING LINKED HEALTH AND LONG-TERM CARE CLAIMS: WHICH IS MORE EXPENSIVE—HOSPITAL DEATH OR LONG-TERM CARE FACILITY DEATH?

BORROWING STRENGTH WITHOUT BORROWING BIAS IN ONCOLOGY USING POWER PRIORS AND COMMENSURATE PRIORS FOR LONG TERM OVERALL SURVIVAL EXTRAPOLATION

EFFECT MODIFICATION BY MULTIMORBIDITY BURDEN ON THE EFFECTIVENESS AND SAFETY OF SGLT2 INHIBITORS IN OLDER ADULTS WITH T2D: A TARGET TRIAL EMULATION STUDY

FINANCIAL HARDSHIP, MEDICATION MANAGEMENT BEHAVIORS, AND PERCEIVED QUALITY OF CARE AMONG MEDICARE BENEFICIARIES

SIX MONTH OUTCOMES AND GLUCAGON-LIKE PEPTIDE-1 (GLP-1) THERAPY PERSISTENCE AMONG COMMERCIALLY INSURED ADULTS WITHOUT DIABETES IN AN OBESITY CARE MANAGEMENT PROGRAM

OPTIMIZING ENDPOINTS FOR CRSWNP BIOLOGIC TRIALS: REGULATORY, HTA, AND PATIENT-CENTERED EVIDENCE REQUIREMENTS

WHERE CAN PATIENTS HAVE AN IMPACT: A DEFINITION TO MEASURE PATIENT IMPACT

THE POTENTIAL EARLY IMPACT OF THE INFLATION REDUCTION ACT ON BUY-SIDE VALUATION METHODOLOGIES AND TRANSACTION STRUCTURING IN THE PHARMACEUTICAL INDUSTRY

INSIGHTS FOR AFFORDABILITY EFFORTS: ANALYZING DRUG AND NON-DRUG SPEND VIA STATE APCDS

SURVEILLANCE OF ADVERSE DRUG REACTIONS TO TRADITIONAL CHINESE MEDICINES: A REAL-WORLD ANALYSIS FROM SHENZHEN, CHINA

IS SUICIDAL IDEATION RISK ASSOCIATED WITH PHARMACOTHERAPY IN ATTENTION-DEFICIT HYPERACTIVITY DISORDER (ADHD)? A REAL-WORLD STUDY

UNDERSTANDING STAKEHOLDER PERSPECTIVES BETWEEN ENDOVASCULAR AND HYBRID REPAIR FOR THORACIC AORTIC ANEURYSMS AND DISSECTIONS INVOLVING THE LEFT SUBCLAVIAN ARTERY

TIME REALLOCATION AMONG ELDER CAREGIVERS IN THE UNITED STATES, 2011-2023

ISPOR–The Professional Society for
Health Economics and Outcomes Research

Your browser is out-of-date